Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1995 1
1997 1
1998 1
1999 2
2000 2
2001 4
2002 6
2003 4
2004 3
2005 1
2006 7
2007 4
2008 7
2009 7
2010 8
2011 4
2012 13
2013 11
2014 8
2015 7
2016 6
2017 10
2018 12
2019 8
2020 3
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity.
Pillow TH, Adhikari P, Blake RA, Chen J, Del Rosario G, Deshmukh G, Figueroa I, Gascoigne KE, Kamath AV, Kaufman S, Kleinheinz T, Kozak KR, Latifi B, Leipold DD, Sing Li C, Li R, Mulvihill MM, O'Donohue A, Rowntree RK, Sadowsky JD, Wai J, Wang X, Wu C, Xu Z, Yao H, Yu SF, Zhang D, Zang R, Zhang H, Zhou H, Zhu X, Dragovich PS. Pillow TH, et al. Among authors: kozak kr. ChemMedChem. 2020 Jan 7;15(1):17-25. doi: 10.1002/cmdc.201900497. Epub 2019 Nov 14. ChemMedChem. 2020. PMID: 31674143
Oxidative metabolism of endocannabinoids.
Kozak KR, Marnett LJ. Kozak KR, et al. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):211-20. doi: 10.1054/plef.2001.0359. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052037 Review.
Oxidative metabolism of endocannabinoids by COX-2.
Kozak KR, Prusakiewicz JJ, Marnett LJ. Kozak KR, et al. Curr Pharm Des. 2004;10(6):659-67. doi: 10.2174/1381612043453081. Curr Pharm Des. 2004. PMID: 14965328 Review.
Calicheamicin Antibody-Drug Conjugates with Improved Properties.
Vollmar BS, Frantz C, Schutten MM, Zhong F, Del Rosario G, Go MAT, Yu SF, Leipold DD, Kamath AV, Ng C, Xu K, Dela Cruz-Chuh J, Kozak KR, Chen J, Xu Z, Wai J, Adhikari P, Erickson HK, Dragovich PS, Polson AG, Pillow TH. Vollmar BS, et al. Among authors: kozak kr. Mol Cancer Ther. 2021 Jun;20(6):1112-1120. doi: 10.1158/1535-7163.MCT-20-0035. Epub 2021 Mar 15. Mol Cancer Ther. 2021. PMID: 33722856
Primary cardiac sarcoma.
Hamidi M, Moody JS, Weigel TL, Kozak KR. Hamidi M, et al. Among authors: kozak kr. Ann Thorac Surg. 2010 Jul;90(1):176-81. doi: 10.1016/j.athoracsur.2010.03.065. Ann Thorac Surg. 2010. PMID: 20609770 Free PMC article.
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response.
Dela Cruz Chuh J, Go M, Chen Y, Guo J, Rafidi H, Mandikian D, Sun Y, Lin Z, Schneider K, Zhang P, Vij R, Sharpnack D, Chan P, de la Cruz C, Sadowsky J, Seshasayee D, Koerber JT, Pillow TH, Phillips GD, Rowntree RK, Boswell CA, Kozak KR, Polson AG, Polakis P, Yu SF, Dragovich PS, Agard NJ. Dela Cruz Chuh J, et al. Among authors: kozak kr. MAbs. 2021 Jan-Dec;13(1):1862452. doi: 10.1080/19420862.2020.1862452. MAbs. 2021. PMID: 33382956 Free PMC article.
Conjugation of Indoles to Antibodies through a Novel Self-Immolating Linker.
Dragovich PS, Blake RA, Chen C, Chen J, Chuh J, den Besten W, Fan F, Fourie A, Hartman SJ, He C, He J, Ingalla ER, Kozak KR, Leong SR, Lu J, Ma Y, Meng L, Nannini M, Oeh J, Ohri R, Lewis Phillips G, Pillow TH, Rowntree RK, Sampath D, Vandlen R, Vollmar B, Wai J, Wertz IE, Xu K, Xu Z, Zhang D. Dragovich PS, et al. Among authors: kozak kr. Chemistry. 2018 Apr 3;24(19):4830-4834. doi: 10.1002/chem.201800859. Epub 2018 Mar 25. Chemistry. 2018. PMID: 29493023
Enantiospecific, selective cyclooxygenase-2 inhibitors.
Kozak KR, Prusakiewicz JJ, Rowlinson SW, Marnett LJ. Kozak KR, et al. Bioorg Med Chem Lett. 2002 May 6;12(9):1315-8. doi: 10.1016/s0960-894x(02)00133-6. Bioorg Med Chem Lett. 2002. PMID: 11965379
131 results